Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe

J Muntwyler, A Cohen-Solai, Nick Freemantle

    Research output: Contribution to journalArticle

    44 Citations (Scopus)

    Abstract

    AIM: To study the role of sex, age and concomitant diseases for prescription of cardiovascular drugs among patients with heart failure cared for in the community. METHODS AND RESULTS: In 15 European countries, a survey was conducted during 1999 and 2000 among 1363 primary care physicians who included 8256 patients with symptoms of heart failure. Predictors of drug prescription were assessed with multivariate logistic regression. Overall prescription rates for ACE-inhibitors/angiotensin receptor blockers (ACE-I/ARB), beta-blockers, digitalis, diuretics and oral anticoagulants were 69%, 30%, 41%, 75% and 18%. Women had no reduced likelihood to receive ACE-I/ARB and beta-blockers (odds ratio [OR]=0.96 [95% CI 0.87-1.06] and 1.02 [0.92-1.13], respectively), but prescription of oral anticoagulants was decreased (OR=0.74, 95% CI 0.65-0.84). Compared to patients
    Original languageEnglish
    Pages (from-to)663-8
    Number of pages6
    JournalEuropean Journal of Heart Failure
    Volume6
    DOIs
    Publication statusPublished - 1 Jan 2004

    Keywords

    • ACE-inhibitors
    • drug utilization
    • oral anticoagulants
    • heart failure
    • beta-blockers
    • quality of care

    Fingerprint

    Dive into the research topics of 'Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe'. Together they form a unique fingerprint.

    Cite this